Stock & Company Details
Enanta Pharmaceuticals Inc $ENTA
Price:
N/A
N/A
29M
$352M
52 Week High:
N/A
10 Day Average Volume:
N/A
-4.66
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
ENTA technical indicators
Latest Enanta Pharmaceuticals Inc (ENTA) indicator readings as of 2026-10-08.
ENTA's 14-day RSI is 42.4, in neutral territory. ADX reads 17.8, indicating a range-bound market rather than a trend. MACD (12, 26, 9) is -0.20, below the zero line.
Overview
Enanta Pharmaceuticals Inc is an American biotechnology company focused on the research and development of molecule drugs to cure viral infections and liver diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.
Finance Bot
Ask your questions
Start by typing a question below.
